Abstract
Over 18.1 million patients worldwide affected by more than 100 different types of cancer. Cancer is one of the critical focuses of medical research today. Researchers have discovered numerous types of cancer, with many patients and a lack of effective unified treatment methods. Therefore, it is urgent to study the pathogenesis and treatment methods. Proteogenomic is an interdisciplinary field focusing on genomics, transcriptomics, and proteomics, which has shown significant effectiveness in tumor analysis and treatment development. Its comprehensive analysis capabilities can help scientists and physicians accurately discover, predict, and treat cancer. This article summarizes the relevant content of using proteogenomic in analyzing and treating various cancers in recent years. It explores the role of proteogenomic in assisting the discovery of new antigens for cancer immunotherapy. This review highlights the latest advancements in proteogenomic and its significant findings in cancer analysis and treatment, suggesting a promising future for its integration into clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Transactions on Materials, Biotechnology and Life Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
